193 related articles for article (PubMed ID: 9110115)
1. Acute and short-term effects of the nonpeptide endothelin-1 receptor antagonist bosentan in humans.
Sütsch G; Bertel O; Kiowski W
Cardiovasc Drugs Ther; 1997 Jan; 10(6):717-25. PubMed ID: 9110115
[TBL] [Abstract][Full Text] [Related]
2. Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure.
Sütsch G; Kiowski W; Yan XW; Hunziker P; Christen S; Strobel W; Kim JH; Rickenbacher P; Bertel O
Circulation; 1998 Nov; 98(21):2262-8. PubMed ID: 9826312
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic effects of bosentan in patients with chronic heart failure.
Kiowski W; Sütsch G; Oechslin E; Bertel O
Heart Fail Rev; 2001 Dec; 6(4):325-34. PubMed ID: 11447307
[TBL] [Abstract][Full Text] [Related]
4. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure.
Kiowski W; Sütsch G; Hunziker P; Müller P; Kim J; Oechslin E; Schmitt R; Jones R; Bertel O
Lancet; 1995 Sep; 346(8977):732-6. PubMed ID: 7658874
[TBL] [Abstract][Full Text] [Related]
5. Short-term hemodynamic effects of endothelin receptor blockade in dogs with chronic heart failure.
Shimoyama H; Sabbah HN; Borzak S; Tanimura M; Shevlyagin S; Scicli G; Goldstein S
Circulation; 1996 Aug; 94(4):779-84. PubMed ID: 8772702
[TBL] [Abstract][Full Text] [Related]
6. Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling.
Mulder P; Richard V; Derumeaux G; Hogie M; Henry JP; Lallemand F; Compagnon P; Macé B; Comoy E; Letac B; Thuillez C
Circulation; 1997 Sep; 96(6):1976-82. PubMed ID: 9323089
[TBL] [Abstract][Full Text] [Related]
7. Bosentan and the endothelin system in congestive heart failure.
Ellahham SH; Charlon V; Abassi Z; Calis KA; Choucair WK
Clin Cardiol; 2000 Nov; 23(11):803-7. PubMed ID: 11097125
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic and neurohumoral effects of selective endothelin A (ET(A)) receptor blockade in chronic heart failure: the Heart Failure ET(A) Receptor Blockade Trial (HEAT).
Lüscher TF; Enseleit F; Pacher R; Mitrovic V; Schulze MR; Willenbrock R; Dietz R; Rousson V; Hürlimann D; Philipp S; Notter T; Noll G; Ruschitzka F;
Circulation; 2002 Nov; 106(21):2666-72. PubMed ID: 12438291
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure: Primary Results of the ENABLE Trials.
Packer M; McMurray JJV; Krum H; Kiowski W; Massie BM; Caspi A; Pratt CM; Petrie MC; DeMets D; Kobrin I; Roux S; Swedberg K;
JACC Heart Fail; 2017 May; 5(5):317-326. PubMed ID: 28449795
[TBL] [Abstract][Full Text] [Related]
10. Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future?
Spieker LE; Noll G; Ruschitzka FT; Lüscher TF
J Am Coll Cardiol; 2001 May; 37(6):1493-505. PubMed ID: 11345356
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients with class III to IV congestive heart failure.
Torre-Amione G; Young JB; Durand J; Bozkurt B; Mann DL; Kobrin I; Pratt CM
Circulation; 2001 Feb; 103(7):973-80. PubMed ID: 11181472
[TBL] [Abstract][Full Text] [Related]
12. Acute effects of an endothelin-1 receptor antagonist bosentan at different stages of heart failure in conscious dogs.
Choussat R; Hittinger L; Barbe F; Maistre G; Carayon A; Crozatier B; Su J
Cardiovasc Res; 1998 Sep; 39(3):580-8. PubMed ID: 9861300
[TBL] [Abstract][Full Text] [Related]
13. The endothelin receptor antagonist, bosentan, in combination with the cyclooxygenase inhibitor, diclofenac, counteracts pulmonary hypertension in porcine endotoxin shock.
Wanecek M; Rudehill A; Hemsén A; Lundberg JM; Weitzberg E
Crit Care Med; 1997 May; 25(5):848-57. PubMed ID: 9187606
[TBL] [Abstract][Full Text] [Related]
14. The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failure.
Schalcher C; Cotter G; Reisin L; Bertel O; Kobrin I; Guyene TT; Kiowski W
Am Heart J; 2001 Aug; 142(2):340-9. PubMed ID: 11479476
[TBL] [Abstract][Full Text] [Related]
15. Effects of a specific endothelin-converting enzyme inhibitor on cardiac, renal, and neurohumoral functions in congestive heart failure: comparison of effects with those of endothelin A receptor antagonism.
Wada A; Tsutamoto T; Ohnishi M; Sawaki M; Fukai D; Maeda Y; Kinoshita M
Circulation; 1999 Feb; 99(4):570-7. PubMed ID: 9927406
[TBL] [Abstract][Full Text] [Related]
16. Endothelin and endothelin receptor antagonism in heart failure.
Sütsch G; Kiowski W
J Cardiovasc Pharmacol; 2000; 35(4 Suppl 2):S69-73. PubMed ID: 10976786
[TBL] [Abstract][Full Text] [Related]
17. Regulation of aldosterone secretion in patients with chronic congestive heart failure by endothelins.
Sütsch G; Bertel O; Rickenbacher P; Clozel M; Yandle TG; Nicholls MG; Kiowski W
Am J Cardiol; 2000 Apr; 85(8):973-6. PubMed ID: 10760337
[TBL] [Abstract][Full Text] [Related]
18. Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study.
Packer M; McMurray J; Massie BM; Caspi A; Charlon V; Cohen-Solal A; Kiowski W; Kostuk W; Krum H; Levine B; Rizzon P; Soler J; Swedberg K; Anderson S; Demets DL
J Card Fail; 2005 Feb; 11(1):12-20. PubMed ID: 15704058
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic and coronary effects of the endothelin antagonist bosentan in patients with coronary artery disease.
Wenzel RR; Fleisch M; Shaw S; Noll G; Kaufmann U; Schmitt R; Jones CR; Clozel M; Meier B; Lüscher TF
Circulation; 1998 Nov; 98(21):2235-40. PubMed ID: 9826308
[TBL] [Abstract][Full Text] [Related]
20. Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure. Acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan).
Teerlink JR; Löffler BM; Hess P; Maire JP; Clozel M; Clozel JP
Circulation; 1994 Nov; 90(5):2510-8. PubMed ID: 7955209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
